Both must adhere to the same standard of care and be compliant with state and federal laws
Month 4 onwards: 25 mg once daily
As clinical use of GLP-1 receptor agonists continues to expand, understanding how these medications alter the subjective/interoceptive effects of alcohol will be critical for optimizing their utility in AUD
N Engl J Med 377:644657 Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS (2019) Dapagliflozin and cardiovascular outcomes in type 2 diabetes
Retrieved from US Food and Drug Administration (FDA-b)
Diabetic kidney disease: a report From an ADA Consensus Conference